# Cresco Labs Inc.: Form 40-F for the period ended Dec 31, 2022

- Company: [Cresco Labs Inc.](/companies/crlbf.md) (CIK 1832928)
- Form: 40-F
- Filed: 2023-03-22
- Accepted by EDGAR: Mar 22, 2023, 06:13 ET
- Period: 2022-12-31
- Accession: 0001832928-23-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1832928/000183292823000003/crlbf-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1832928/000183292823000003/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $842.7m | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $435.7m | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2022-01-01 to 2022-12-31 | $407.0m | ifrs-full:GrossProfit |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$84.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $88.9m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$212.0m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.71 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.71 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | $18.7m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $83.0m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2022-12-31 | $119.3m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-12-31 | $326.0m | ifrs-full:CurrentAssets |
| Total assets | at 2022-12-31 | $1.58bn | ifrs-full:Assets |
| Current liabilities | at 2022-12-31 | $280.9m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-12-31 | $996.0m | ifrs-full:Liabilities |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1832928/000183292823000003/crlbf-20221231.htm

Filed Mar 22, 2023.
Source: SEC EDGAR, the filing index for accession 0001832928-23-000003. Last ingested by Listed: Nov 6, 2026, 12:03 ET. No prices; not investment advice.